GTR 113661812

Bids Are Invited For Central Purchase - Iv Medicines

ICB — International Competitive Bid Closed South America
Tender Information
GTR Reference
113661812
Tendering Authority
Subscribe to view
Tender No
91/2026
Financer Name
Self-Funded
Work Title
Bids Are Invited For Central Purchase - Iv Medicines
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
11-06-2026 Closed
Work Detail
Abemaciclib Active Ingredient: Abemaciclib; Concentration/Dosage: 150 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Component: .;, Retinol Acetate + Associations - Active Ingredient (1): Retinol Acetate + Amino Acids; Active Ingredient (2): Methionine + Chloramphenicol; Concentration, Acetazolamide - Active Ingredient: Acetazolamide; Concentration/Dosage: 250 Mg; Pharmaceutical Form: Tablet; Presentation: .; Component: .;, Alectinib - Active Ingredient: Alectinib; Concentration/Dosage: 150 Mg; Pharmaceutical Form: Capsule; Presentation: .; Component: .;, Amantadine - Active Ingredient: Amantadine, Hydrochloride; Concentration/Dosage: 100 Mg; Pharmaceutical Form: Tablet; Presentation: .; Component: .;, Ambrisentana - Active Ingredient: Ambrisentana; Concentration/Dosage: 10 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Component: .;, Ambrisentana - Active Ingredient: Ambrisentana; Concentration/Dosage: 5 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Component: .;, Amphotericin B - Active Ingredient: Liposomal Amphotericin B; Concentration/Dosage: 50 Mg; Pharmaceutical Form: Powder For Infusion Solution; Presents, Asparaginase - Active Ingredient: Asparaginase; Concentration/Dosage: 10,000 Iu; Pharmaceutical Form: Freeze-Dried Powder; Presentation: Vial-Ampule; Compon, Benralizumab - Active Ingredient: Benralizumab; Concentration/Dosage: 30 Mg/Ml; Pharmaceutical Form: Injectable Solution; Presentation: Prefilled Syringe, Betamethasone - Active Ingredient: Betamethasone, Disodium Phosphate; Concentration/Dosage: 5.3 Mg/Ml; Equivalence: 4 Mg/Ml Of Betamethasone; Farmace Form, Biperiden - Active Ingredient: Biperiden; Concentration/Dosage: 5 Mg/Ml; Pharmaceutical Form: Injectable Solution; Presentation: 1 Ml Ampoule; Component: Brentuximab - Active Ingredient: Brentuximab Vedotin; Concentration/Dosage: 50 Mg; Pharmaceutical Form: Lyophilized Powder For Injectable Solution; Apresen, Brigatinib - Active Ingredient: Brigatinib; Concentration/Dosage: 30 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Component: .;, Brigatinib - Active Ingredient: Brigatinib; Concentration/Dosage: 90 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Component: .;, Umeclidinium Bromide Active Ingredient: Umeclidinium Bromide; Concentration/Dosage: 62.5 Mcg; Pharmaceutical Form: Powder For Oral Inhalation; Presentation, Budesonide + Associations - Active Ingredient: Budesonide + Formoterol Fumarate; Concentration/Dosage: 200 Mcg + 6 Mcg; Pharmaceutical Form: Powder Inalant, Budesonide + Associations - Active Ingredient: Budesonide + Formoterol Fumarate; Concentration/Dosage: 400 Mcg + 12 Mcg; Pharmaceutical Form: Inalan Powder, Carbachol - Active Ingredient: Carbachol, Chloride; Concentration/Dosage: 0.1 Mg/Ml; Pharmaceutical Form: Ophthalmic Solution; Presentation: 2 M Vial, Cetuximab - Active Ingredient: Cetuximab; Concentration/Dosage: 5 Mg/Ml; Pharmaceutical Form: Injectable Solution; Presentation: 100 Ml Bottle; Component, Cetuximab - Active Ingredient: Cetuximab; Concentration/Dosage: 5 Mg/Ml; Pharmaceutical Form: Injectable Solution; Presentation: 20 Ml Ampoule Bottle; With, Cladribine - Active Ingredient: Cladribine; Concentration/Dosage: 1 Mg/Ml; Pharmaceutical Form: Injectable Solution; Presentation: 8 Ml Ampoule Bottle; Comp, Calcium Chloride - Active Ingredient: Calcium Chloride; Concentration/Dosage: 100 Mg/Ml (10%); Pharmaceutical Form: Injectable Solution; Via De Administr, Potassium Chloride - Active Ingredient: Chloride
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
688c5711-160d-4f6a-8320-04178a4b0bd5.html
Attachments
Additional Details Available on Click
  • Tendering Authority
  • Publication Document (Tender Document / Tender Notice)
Disclaimer

We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.

Tell us about your Product / Services,

We will Find Tenders for you

TenderDetail
Loading tenders